Omeros Corporation (OMER): Income And Excitement Are Things Omeros Offers
Filed under: drug addiction treatment options
The company's PDE10 inhibitor OMS824, under evaluation for treating psychiatric conditions, has gotten a strange amount of attention for a drug candidate that has not entered Phase 2 trials. In fact, an article published just over … It may have …
Read more on Seeking Alpha
Orexo receives US FDA approval for Zubsolv for treatment of opioid dependence
Filed under: drug addiction treatment options
Orexo US, Inc., an emerging specialty pharmaceutical company marketing improved treatments for opioid dependence using proprietary drug delivery technology, has received approval from the US Food and Drug Administration (FDA) for Zubsolv (buprenorphine …
Read more on pharmabiz.com